Bahrain is expanding domestic production of pharmaceuticals to take advantage of a GCC market that is expected to be worth $85bn.
Bahrain Pharma has secured regulatory approval from Bahrain’s National Health Regulatory Authority (NHRA) to produce gel capsule and soluble syrups in a move which will create high-skilled pharmaceutical manufacturing jobs.
☛ Want to stay up to date with the news? Sign up to our daily bulletin.